Hicks Returns to White Sox Bullpen After Six-Week Lat Injury

Jordan Hicks is back. The Chicago White Sox reinstated the 29-year-old right-hander from the 15-day injured list ahead of Sunday's series finale at Detroit, ending a six-week absence that began May 21 with a right lat strain. Hicks made three appearances during his rehab stint at Class AAA Charlotte and is available for immediate relief work—a meaningful upgrade to a bullpen that has leaned heavily on Tyler Davis, who the Sox optioned back to Charlotte to make roster space.

The context here matters. Hicks' injury timeline (May 21 through mid-June return) compressed his 2026 season into a narrow window just as the White Sox were fighting for footing in what has been a difficult year. His 20 relief appearances before the injury carried a 5.60 ERA and 15 strikeouts across 17.2 innings—a 7.63 K/9 rate that lags behind his career velocity profile. That's not mechanical decline; lat strains typically affect extension and release point, which suppress strikeout rates even after the player is deemed healthy enough to pitch. The three Charlotte rehab games saw him work his way back into rhythm, but regular-season velocity and command data won't be available until he faces major-league hitters.

Davis, the optioned reliever, compiled a 4.63 ERA with a microscopic .198 opponents average in 22 appearances—an unusual split that suggests he was outperforming his underlying stuff. A 20 K in 23.1 innings (7.73 K/9) is solid for a rookie, but the ERA floor implied by that opponent average rarely holds. The White Sox clearly view the Hicks return as a net upgrade in leverage innings, which is a voting signal in itself—they paid for the ability to pitch a known arm in high-leverage spots rather than trust the continuation of Davis' statistical luck.

For bettors, the angle centers on Hicks' strikeout props in his first 5–7 appearances back. His pre-injury K/9 (7.63) will likely settle higher once he's fully stretched out and his extension returns to baseline, but the opening line on strikeouts over the next 2–3 weeks may still price him at a depressed rate that accounts for injury uncertainty. The market tends to shade conservatively on returning injury cases, especially with a 6-week absence. If his fastball sits where it did pre-injury (mid-95s range), he will outpace a cautious early line. However, if the lat continues to affect his finish, those strikeout props will flatten out just as quickly. This is a high-volatility edge tied to one specific window—the next 10 days before the market corrects on live data.